Lung Cancer Clinical Trial

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Summary

The purpose of this study is to test if our Community Health Worker program can help at-risk NYC Chinese community members participate in shared decision making and lung cancer screening (if appropriate) and compare it to the help provided by written materials.

View Full Description

Full Description

The study first used qualitative methods to inform the adaptation of a CHW model to facilitate lung cancer screening completion in an extremely high-risk group, NYC Chinese livery drivers who smoke or who quit within the past 15 years. A series of focus groups with Chinese livery drivers who smoke, a series of in-depth interviews with livery base management and staff, primary care physicians (PCPs), clinic directors, hospital CFOs, heads of financial services and counseling, and heads of radiology facilities serving the Chinese community were conducted to explore barriers and factors related to cancer screening. Findings were used to develop adapted intervention materials, including a CHW Manual for Facilitating Shared Decision Making and Lung Cancer Screening. Once adaptation is complete, the researchers will conduct a pre-pilot to refine the adapted CHW intervention materials. The researchers will then conduct a pilot randomized controlled trial (RCT) to assess the feasibility of the refined CHW model (intervention) versus written materials (control) to facilitate SDM and LCS (when appropriate) in an extremely high-risk group, NYC Chinese livery drivers eligible (by USPTSF criteria) for LCS. Feasibility results will be used to inform the planning and design of large scale RCTs, targeting Chinese drivers, as well as other driver populations in NYC and throughout the U.S., and other high risk Chinese smoking populations in other occupations (e.g. restaurant work, construction). The study is currently in the pre-pilot phase and expects to launch the pilot phase by the summer of 2020. Due to the effects of the COVID-19 crisis, the researchers have extended the pre-pilot participation time frame to 12 months. The study population has also indicated concern to attend doctor's appointments for SDM/LCS during COVID-19. As such, MSK is extending the study time frame to an additional 6 months. . CHWs will also be hosting health education workshops at community organizations, family associations, and public libraries. These workshops will be conducted in English, Mandarin, and Cantonese and cover topics including smoking cessation and lung cancer screening.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Focus Group Participants:

Of Chinese descent
Non-U.S. born
Fluent in Mandarin
Livery driver
Age 45-80
Current or past (within 15 years) cigarette smoker (no specific pack year requirement)

In Depth Interview Participants Livery Staff

Of Chinese descent
Non-U.S. born
Fluent in Mandarin
Livery base owner or employee
Age ≥ 21

Health Care Providers and Administrators:

Primary care physician, clinic director, hospital administrator, or radiology facility or department administrator
Age ≥ 21
Fluent in English

CHW pre-pilot RCT participants:

Of Chinese descent
Fluent in Mandarin
Male
Livery driver
Age 55-80 years old
Driven for 3 months or longer
30 pack year history
Current smoker or quit within 15 years
Will not be traveling out of New York Area for more than 1 month in the next 3 months

CHW pilot RCT participants

Of Chinese descent
Fluent in Mandarin or Cantonese
Male
Professional driver
Age 50-80 years old
Driven for 3 months or longer
Last drove professionally within the last 18 months with plans of returning
20 pack year smoking history
Current smoker or quit within 15 years
Will not be traveling out of New York Area for more than 3 months in the next 12 months
Has not completed LDCT in the past year.

Exclusion Criteria:

Has a household member who has already participated (or agreed to participate).

Study is for people with:

Lung Cancer

Phase:

Early Phase 1

Estimated Enrollment:

99

Study ID:

NCT02914899

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Early Phase 1

Estimated Enrollment:

99

Study ID:

NCT02914899

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.